Register to PHPLD
Lost password?

AXIS Clinicals announces successful completion of 13th US FDA Audit

Date Added: April 07, 2014 06:22:48 AM
Author: Abhijit Chaudhari
Category: Health: Medicine

AXIS Clinicals announces successful completion of 13th US FDA Audit Friday, 21 March 2014 Hyderabad, INDIA – AXIS Clinicals Limited, the leading Clinical Research Organization (CRO), announces today that its Hyderabad, India based Clinical Pharmacology Units (CU-I and CU-II) successfully completed its 13th US FDA Audit without 483s / observations. US FDA Investigator audited the First-to-File studies for one of AXIS Clinicals’ sponsor. The audit covered the review of several studies, general processes and systems inspection. The latest US FDA Audit with NO 483’s is a resounding success for AXIS Clinicals Team. Having a successful US FDA audit for the First-To-File product, along with the Brazilian ANVISA, UK MHRA, France-AFSSAPS, Turkey MOH and NABL certification, demonstrates that AXIS Clinicals has attained the Quality Standards laid by international regulatory bodies. AXIS Clinicals continued successful audit track record confirms that the company's quality system meet the requirements established by the US, Canada, Europe, Brazil, Australia, South Africa, Turkey, Malaysia and other international regulatory authorities. About AXIS Clinicals AXIS Clinicals Limited is a Contract Research Organization headquartered in Hyderabad, India with the global footprint of operations in United States, Mexico and Thailand, committed to serving the biopharmaceutical industry with the global standards and most accurate results. AXIS Clinicals specializes in the conduct of Bioequivalence / Bioavailability studies, Phase / Clinical Trials and bioanalysis for innovative pharmaceutical, biotech and medical device companies. AXIS Clinicals has completed 1500+ studies for global regulatory submissions. AXIS Clinicals has the world-class infrastructure with 292-bed clinical facility and a co-located bioanalytical laboratory in Hyderabad, India. About First-To-File product: The first-to-file status comes with 180-day marketing exclusivity (from the date of approval of the ANDA). During this exclusivity period, the first-to-file generic company can realize enormous profits on the sale of the generic drug before other generic product enter the market. AXIS Clinicals Limited 1-121/1,Miyapur,Hyderabad 500 049,INDIA Web : www.axisclinicals.com Email : BD@axisclinicals.com
  • Latest Links

    N/A
    QuickBooks Payroll Support Number

    Call (844)827-3817 Intuit QuickBooks Payroll Support Phone Number for Basic, Enhanced, Full-Service or QB Desktop payroll, MAC Payroll software. 24/7 Payroll support by Intuit Certified on Toll Free 800 Intuit telephone . Resolve Employee payroll to tax filing, Payroll Update, Upgrade errors .Read more

    https://payroll.accountingerrors.com/
    (0 Reviews. Rating: Total Votes: )
    N/A
    Cost of Hair Transplant in Mumbai

    Cost of hair transplant in mumbai start at 35k, Hair transplant Cost depend on patient baldness area and number of graft they require for surgery. Nutrite Hair Transplant equipped with EMI and Loan Facility makes your surgery so affordable and effective with best result.Read more

    http://nutritehairtransplant.com/
    (0 Reviews. Rating: Total Votes: )
    N/A
    swass products

    Swaas products are truly a breath of fresh air. Our products are created to provide a safe and healthy lifestyle. All of our energy and passion goes into formulating and creating the finest products free of harmful chemicals.Read more

    http://swaasproducts.com
    (0 Reviews. Rating: Total Votes: )
    N/A
    Arscorporis

    [No Description]Read more

    http://www.arscorporis.hu
    (0 Reviews. Rating: Total Votes: )
    N/A
    Herbal Ayurved & Research Center

    We are provide to different products of Health and BeautyRead more

    http://herbalgroup.org
    (0 Reviews. Rating: Total Votes: )
  •